Sign in

Novel Compounds Point Toward the Future of Healthier, Better-tasting Flavors

Contact Author Jeb Gleason-Allured, Editor
Close
Fill out my online form.
Ray Salemme

Ray Salemme, CEO, Redpoint Bio

This is only an excerpt of the full article that appeared in P&F Magazine. The full content is not currently available online.

The sequencing of the human genome has elucidated, among countless other things, the taste signaling pathway in the tongue. Meanwhile, the desire for healthier food options among food and beverage companies and consumers—particularly the reduction of sodium and sugar—has increased exponentially. As a result, a number of biotech firms have emerged to tackle the manipulation of taste receptors and signals in the interest of modifying flavors.

Building on the core knowledge of founder Robert Margosklee (professor of neuroscience, structural and chemical biology, and pharmacology and systems therapeutics at Mount Sinai in New York), Redpoint Bio (Ewing, New Jersey) approaches the research and discovery of sweet and salt enhancers, bitter blockers, and spice modulators from a drug discovery background. CEO Ray Salemme explains that the company has applied that background to the science of flavors, originally focusing on bitter blockers for orally dissolving prescription drug and OTC tablets and films. Whether it’s the delivery of acetaminophen, diphenhydramine hydrochloride or ranitidine, aversive taste is a primary roadblock for the feasibility of these orally applied drugs. The efficacy and toxicological advantages of such drug delivery created the company’s first avenue of research, which quickly expanded to applications for foods and beverages as researchers discovered taste enhancers. Aside from expanding its expertise, the move into developing materials for flavors presents the added advantage of a relatively brief approval process. While clearing a material through the US Food and Drug Administration can sometimes take more than five years, approval of a flavor material via the Flavor and Extract Manufacturers Association’s GRAS process costs significantly less and takes just 12–18 months.

Sweet and Savory/Salt Enhancers

The guiding principle of Redpoint Bio’s research is to improve the nutrition and taste of foods and beverages. As Scott Siegel, vice president of corporate development, notes, the ability to reduce sugar and sodium content in products has mutually beneficial health and fiscal ramifications so long as there is no attendant loss of flavor quality. Rather than focusing on cell surface receptors on the tongue, Redpoint Bio’s technology largely works downstream in the cellular pathway, targeting the transmission of receptor signals. The company’s enhancers and blockers work, respectively, by holding the TRP5 taste channel open or closed, a phenomenon Siegel likens to “turning the volume up or down” on targeted taste sensations. (There is additional evidence, based on the work of Margosklee and others, that these taste signaling modulators could also be used to treat diabetes and obesity by manipulating the body’s metabolic reaction to tastants sensed in the human gut. See: RF Margolskee, J Dyer, Z Kokrashvili, KSH Salmon, E Ilegems, K Daly, EL Maillet, Y Ninomiya, B Mosinger and SP Shirazi-Beechey, T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter. Proceedings of the National Academy of Sciences, 104 (38), 15075–15080.)

Related Content

 

Close

Scott Siegel, Redpoint Bio

Scott Siegel

Next image >